Okada Toshihiko, Hiromura Makoto, Otsuka Masato, Enomoto Shuichi, Miyachi Hiroyuki
Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, 1-1-1 Tsushima-Naka, Kita-ku, Okayama 700-8530, Japan.
Chem Pharm Bull (Tokyo). 2012;60(1):164-8. doi: 10.1248/cpb.60.164.
Adipocyte fatty acid binding protein (A-FABP; FABP4), which is predominantly expressed in macrophages and adipose tissue, regulates fatty acid storage and lipolysis, and is also an important mediator of inflammation. Here, we report a synthesis of (14)C-labeled 2-[2'-(5-ethyl-3,4-diphenyl-1H-pyrazol-1-yl)biphenyl-3-yloxy]acetic acid (BMS309403), a potent and selective small-molecular FABP4 inhibitor, as a chemical tool for investigating the roles of FABP4 in inflammatory and metabolic disorders. The structure-activity relationship of several BMS derivatives for inhibition of FABP4 is also reported.
脂肪细胞脂肪酸结合蛋白(A-FABP;FABP4)主要在巨噬细胞和脂肪组织中表达,调节脂肪酸储存和脂解,也是炎症的重要介质。在此,我们报道了一种(14)C标记的2-[2'-(5-乙基-3,4-二苯基-1H-吡唑-1-基)联苯-3-基氧基]乙酸(BMS309403)的合成方法,它是一种强效且选择性的小分子FABP4抑制剂,作为研究FABP4在炎症和代谢紊乱中作用的化学工具。还报道了几种BMS衍生物抑制FABP4的构效关系。